News

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...
A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...
The Dubs might not have the same strength in their numbers that they once boasted. Curry and Draymond Green’s legs might not ...
The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
Few of Elon Musk’s companies would have been possible without the energy density and stability of lithium-ion batteries. In 2019, John B. Goodenough (University of Texas, Austin) shared the Nobel ...
Today the concept of academic freedom may seem obvious to Americans. But the roots of academic freedom, which can be traced ...
Founded in 2013 and headquartered in Zug, Switzerland, CRISPR is leveraging the Nobel Prize-winning CRISPR/Cas9 technology to develop transformative therapies. CRISPR aims to cure genetic ...
To better understand what NGTs are and how they work, Euronews Tech Talks went to Hertfordshire, a county just north of ...
The company, co-founded by Jennifer Doudna, the scientist who won a Nobel Prize for her CRISPR discoveries, uses CRISPR to edit T cells sourced from healthy donors. Those edits enable these one ...